Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 355, pseudogene (RNU6-355P) is classified as a pseudogene corresponding to a U6 small nuclear RNA (snRNA) locus. U6 snRNA itself plays an essential role as a component of the spliceosome, the molecular machine that removes introns from pre-mRNA during splicing, but RNU6-355P is a non-coding pseudogene and does not produce a functional RNA or protein product[1][3][5]. Pseudogenes such as RNU6-355P are considered "genomic fossils" and typically lack biological activity. Unlike functional U6 snRNA genes, pseudogenes like RNU6-355P are not involved in canonical cellular processes and have not been established as therapeutic targets, disease biomarkers, or mechanisms for drug action[1][4]. There are no known drugs or disease roles attributed to this locus. Key points: - RNU6-355P is a non-functional pseudogene related to the U6 snRNA gene. - U6 snRNA is critical to RNA splicing, but RNU6-355P does not produce functional small nuclear RNA[3][5]. - There is no evidence establishing RNU6-355P as a therapeutic target, disease-associated locus, or biomarker. - No known interacting drugs or mechanisms of action are associated with this pseudogene. - It is not a canonical target in pharmacology or molecular medicine. There is nothing intrinsically "wrong" with the nomenclature, but the entry likely does not represent an actionable or biologically functional target; hence `is_incorrect` should be flagged as true for drug/discovery purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 355, pseudogene (RNU6-355P).